XML 40 R9.htm IDEA: XBRL DOCUMENT
v3.20.1

Revenue Recognition | 3 Months Ended
--- | ---
Mar. 31, 2020
Revenue Recognition [Abstract] |
Revenue Recognition | REVENUE RECOGNITION Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2019. We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.
Net Sales by Product Line |  |
| Three Months
| 2020 | 2019
Orthopaedics: |  |
Knees | $ | 432 |  | $ | 439 |
Hips | 316 |  | 336 |
Trauma and Extremities | 392 |  | 396 |
Other | 82 |  | 79 |
| $ | 1,222 |  | $ | 1,250 |
MedSurg: |  |
Instruments | $ | 513 |  | $ | 461 |
Endoscopy | 455 |  | 470 |
Medical | 587 |  | 531 |
Sustainability | 67 |  | 65 |
| $ | 1,622 |  | $ | 1,527 |
Neurotechnology and Spine: |  |
Neurotechnology | $ | 483 |  | $ | 469 |
Spine | 261 |  | 270 |
| $ | 744 |  | $ | 739 |
Total | $ | 3,588 |  | $ | 3,516 |
Net Sales by Geography |  |  |  |  |
| Three Months 2020 |  | Three Months 2019
| United States | International |  | United States | International
Orthopaedics: |  |  |  |  |
Knees | $ | 322 |  | $ | 110 |  |  | $ | 320 |  | $ | 119 |
Hips | 201 |  | 115 |  |  | 213 |  | 123 |
Trauma and Extremities | 260 |  | 132 |  |  | 254 |  | 142 |
Other | 69 |  | 13 |  |  | 63 |  | 16 |
| $ | 852 |  | $ | 370 |  |  | $ | 850 |  | $ | 400 |
MedSurg: |  |  |  |  |
Instruments | $ | 410 |  | $ | 103 |  |  | $ | 365 |  | $ | 96 |
Endoscopy | 364 |  | 91 |  |  | 376 |  | 94 |
Medical | 454 |  | 133 |  |  | 416 |  | 115 |
Sustainability | 66 |  | 1 |  |  | 64 |  | 1 |
| $ | 1,294 |  | $ | 328 |  |  | $ | 1,221 |  | $ | 306 |
Neurotechnology and Spine: |  |  |  |  |
Neurotechnology | $ | 301 |  | $ | 182 |  |  | $ | 300 |  | $ | 169 |
Spine | 196 |  | 65 |  |  | 208 |  | 62 |
| $ | 497 |  | $ | 247 |  |  | $ | 508 |  | $ | 231 |
Total | $ | 2,643 |  | $ | 945 |  |  | $ | 2,579 |  | $ | 937 |
Contract Assets and Liabilities On March 31, 2020 there were no contract assets recorded on our Consolidated Balance Sheets. Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $361 and $313 on March 31, 2020 and December 31, 2019.

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI http://asc.fasb.org/topic&trid=49130388 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -URI http://asc.fasb.org/topic&trid=2122369 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration